Navigation Links
CardioTech Announces Conference Call on February 12 at 2:30 PM Eastern for Third Quarter of Fiscal 2008
Date:2/5/2008

WILMINGTON, Mass., Feb. 5 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (Amex: CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, announced today that it will release its fiscal 2008 third quarter financial results before the market opens on Tuesday, February 12, 2008. Following the release, the Company will host a conference call for investors at 2:30 p.m. ET (11:30 a.m. PT) to discuss its fiscal third quarter results and recent developments.

Participants should dial-in (866) 802-4355 Conference ID# 1191648 or (703) 639-1323 outside the U.S. Please dial-in 10 minutes before the call is scheduled to begin. A replay of the call will be available for two weeks following the call at (888)-266-2081 ID# 1191648 and on the Company's website.

About CardioTech International:

CardioTech is a developer of advanced polymer materials and manufacturer of medical products for the treatment and diagnosis of a broad range of disease states. The Company's business model leverages its proprietary materials science technology and manufacturing expertise in order to expand its product sales and royalty and license fee income. It develops next generation polymers and manufactures new and complex medical devices to customers' unique specifications. CardioTech is conducting its first clinical trial for regulatory approval in Europe for its CardioPass synthetic coronary bypass graft. More information about CardioTech is available at its website: http://www.cardiotech-inc.com.

For Further Information Contact:

Eric Walters

Vice President & Chief Financial Officer

C
'/>"/>

SOURCE CardioTech International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)..., Dec. 4 Researchers are taking a ...kinase) pathway as studies continue to demonstrate...tumor growth, reports Genetic Engineering & B...in angiogenesis, cell growth, differentiation, and...mTOR pathway, which plays a key role in cancer, ac...
(Date:12/4/2008)...la., Dec. 4 Imaging Diag... a pioneer in laser optical breast,imaging, annou...stem as an,adjunct to mammography is featured in ... (Logo: http://www.newscom.com/cgi-bin/prn...MD, a radiologist at Charite Hospital in Berlin,...
(Date:12/4/2008)... Dec. 4 Raymond J. De Ho...o Corporation (NYSE: MPR ), announced today that ... on December 3, 2008, declared a quarterly dividen...shareholders of record at the close of business on...1% increase over the same period last year. , ...
(Date:12/4/2008)... Azur Pharma Limited ("Azur") toda... agreement with BioSante,Pharmaceuticals, Inc ("B...to,Elestrin(TM). Elestrin is a fast drying gel fo... treatment of moderate to severe vasomotor symptom...d by the U.S. Food and Drug,Administration ("FDA"...
Breaking Biology Technology:GEN Reports Growing Focus on PI3-Kinase Pathway in Cancer Research 2Imaging Diagnostic Systems CT Laser Mammography (CTLM) Technology Featured in Peer-Reviewed Journal 2Met-Pro Corporation Declares Quarterly Dividend 2Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2
...Roy came into CUNA Mutual Groups IT shop, he wasnt...His predecessor, Steve Haroldson, retired leaving ... business and was delivering on its operational pr...k needed a sophisticated approach to build on thes...at when you tie IT to financial services, the situ...
... Wis. Despite all the financial and mental effor...arketing it will never get past a limited release ...arch moving further into the spotlight is the Wis...ated as a Whitewater-based division of the Univers...ment Center, designed to provide inventors and ent...
...kee County Research Park Center. ZyStor will have ...million from a venture-capital syndicate has drawn...nsin, where it will inhabit brand-new lab faciliti...pany is targeting a type of debilitating genetic d...ldren, using a new technique. , , Symbiontics, Inc...
...t 10,000 jobs Berbee ranks highly in Microsoft ...bought by local system Wausau police nab suspec... SBC Communications , the parent company of SBC Wi...next year, the company reported in filings with th... does not know how many of the cut positions will ...
Other Biology Technology:CIO of CUNA Mutual Group talks on business-IT fusion 2CIO of CUNA Mutual Group talks on business-IT fusion 3UW-Whitewater center helps inventors get to market 2UW-Whitewater center helps inventors get to market 3UW-Whitewater center helps inventors get to market 4Wisconsin VCs draw Missouri biotech firm to state 2Wisconsin VCs draw Missouri biotech firm to state 3Wisconsin VCs draw Missouri biotech firm to state 4Tech Digest: whats moving in the Midwest (11/8/04) 2
(Date:12/3/2008)...t,s number one at the box office this week. The mo...gs of the body, filmed by scientists using ground-...stralia, scientists at Sydney,s Centenary Institut...a parasite and followed the infection as it begins...fgang Weninger, head of the Immune Imaging program...
(Date:12/3/2008)...Mo. "FORE"...Though they may not help improve a p... the way golfers think about the local country clu...f Missouri study. , "There are more than 17,000 ...ly 70 percent of that land is not used for playing...ogy in the MU College of Arts and Science. "These ...
(Date:12/3/2008)...rmless virus to insert a corrective gene into mous...esearch Hospital have alleviated sickle cell disea...und that the treated mice showed essentially no di... caution that applying the gene therapy to humans ...ieve that the new therapy will become an important...
(Date:12/3/2008)...he outstanding success of the first tandem mission...ed the two satellites together again to help impro...,s veteran spacecraft, and Envisat, the largest en...etic Aperture Radar (SAR) instruments that provide...,By combining two or more SAR images of the same ...
Breaking Biology News(10 mins):Scientists film inner workings of the immune system 2Golf course: Playing fields, wildlife sanctuaries or both 2Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3ESA satellites flying in formation 2Researchers expand efforts to explore functional landscape of the human genome 731 1Researchers expand efforts to explore functional landscape of the human genome 731 2Researchers expand efforts to explore functional landscape of the human genome 731 3Researchers expand efforts to explore functional landscape of the human genome 731 4Researchers expand efforts to explore functional landscape of the human genome 731 5Researchers expand efforts to explore functional landscape of the human genome 731 6Gates Foundation Launches 24100 Million Initiative to Spur Innovation in Global Health Research 3222 1Gates Foundation Launches 24100 Million Initiative to Spur Innovation in Global Health Research 3222 2Gates Foundation Launches 24100 Million Initiative to Spur Innovation in Global Health Research 3222 3Fundraiser Announced for Morongo Fire Chief 3B Veteran Firefighter Diagnosed With ALS 3217 1Fundraiser Announced for Morongo Fire Chief 3B Veteran Firefighter Diagnosed With ALS 3217 2Fundraiser Announced for Morongo Fire Chief 3B Veteran Firefighter Diagnosed With ALS 3217 3Salugen to Present at Nutrition Capital Networks First In Person Investor Meeting 1154 1Salugen to Present at Nutrition Capital Networks First In Person Investor Meeting 1154 2
...nstitute, the Marine Biological Laboratory (MBL) i...Health Sciences Center have discovered the presenc...he organizing structure inside each cell that assu...d June 5 in the online early edition of the journa... present evidence that individual centrosomes with...
... either preventing or promoting the cell death, a ...provides proof in principle that pharmacological i...th in situations where this is not desirable, such...s patients, but to promote cell death in cancer ce...," says lead researcher Peter Greer of two studies...
...mean that 2006 is shaping up as the worst year for...according to Art Shapiro, professor of evolution a... last spring, when millions of painted lady butter...er species have seen steep declines in recent year..., "It has been the worst spring for butterflies o...
...cular disease and cancer in Asia where people smok...umption of tea, particularly green tea, according ...Medicine researcher. , "We do not yet have a full ...to the very low incidence of both heart disease an...ettes is greater than in most other countries," sa...
Other Biology News:RNA found in the cellular centrosome of surf clams 2Protein's role in regulating cell death sets direction for cancer research 2Where have all the butterflies gone? 2Green tea and the 'Asian Paradox' 2
GOAT ANTI HUMAN FACTOR 8RELATED ANTIGEN
2,4,6-Trinitrophenyl hapten is conjugated to Bovine Serum Albumin protein through lysine by amide bonds.
EoProbe Eosinophil Staining Kit, 1 Kit
B.D. Hames and D.M. Glover (1996) • This issue covers T-Cell antigen receptor genes; T-Lymphocyte signal transduction; B-Cell activation antibody engineering and the complement system and other
Biology Products: